๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
NCT07189065Diffuse Large B-Cell Lymphoma (DLBCL)
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 2
150
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Meizhou, Nanning, Shijiazhuang
2025-11-27
Recruiting
A Prediction Model in Pregnant Women With Aplastic Anemia
NCT07101770Aplastic Anemia, Pregnancy, Prediction Model
Peking University People's Hospital
Observational
300
Beijing
2025-11-27
Recruiting
YSCH-01 Via Nebulization in Pulmonary Metastasis of Advanced Solid Tumors and Non-small Cell Lung Cancer (NSCLC)
NCT07793500NSCLC, Advanced Solid Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
36
Beijing
2025-11-27
Active, closed
Parent-administered Pediatric Tuina Versus Routine Care for Pediatric Functional Dyspepsia
NCT07369687Pediatric Functional Dyspepsia
The Hong Kong Polytechnic University
Not applicable
50
Hong Kong
2025-11-27
Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
NCT07236099Prurigo Nodularis (PN)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
135
Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Jingzhou, Changsha
2025-11-27
Recruiting
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)
NCT07108270Neoplasms, Endometrial
GlaxoSmithKline
Phase 2
30
Jinan
2025-11-27
Recruiting
Establishment of a Multimodal Standard Database for Inflammation-related Ophthalmopathy
NCT07628946Ocular Surface Disease, Inflammatory Disease, Retinal Disease, Choroid Diseases
Dan Chen
Observational
3,000
Beijing
2025-11-26
Active, closed
A Clinical Study Evaluating the Efficacy and Safety of CreNeuriS CNS Herbal Nutrition Capsules for Participants With Mild Depressive Disorder Comorbid With Anxiety Disorder
NCT07295444Mild Depressive Disorder Comorbid With Anxiety Disorder
Second Affiliated Hospital of Nanchang University
Not applicable
30
Nanchang
2025-11-26
Recruiting
Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
NCT07160608Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Alexion Pharmaceuticals, Inc.
Phase 2
75
Baotou, Beijing, Guangzhou, Hangzhou, Nanchang, Shenzhen
2025-11-26
Recruiting
A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer
NCT07217301IO-resistant sqNSCLC
Takeda
Phase 3
600
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Harbin, Xinxiang
2025-11-26
Recruiting
Single-dose,First-in-human of KLA478
NCT07240675Healthy Volunteers
Hunan Kelun Pharmaceutical Co., Ltd.
Phase 1
40
Shanghai
2025-11-26
Recruiting
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
NCT07227402Renal Cell Carcinoma
Merck Sharp & Dohme LLC
Phase 3
904
2025-11-26
Recruiting
Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial
NCT07279077Colon Cancer, Neoadjuvant Therapies, Immune Checkpoint Therapy, Radiation Therapy
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
38
Guangzhou
2025-11-26
Recruiting
A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease
NCT07640893Von Willebrand Disease (VWD)
Shanghai RAAS Blood Products Co., Ltd.
Phase 2
24
Changsha, Hefei, Jinan, Nanning, Suzhou, Taiyuan, Tangshan, Tianjin
2025-11-26
Recruiting
Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study
NCT07247968Esketamine, ECT, Depression, Adolescent
Min Su
Phase EARLY_PHASE1
220
Chongqing
2025-11-25
Recruiting
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide
NCT07537699Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hangzhou
2025-11-25
Active, closed
Effect of Perception-based Interventions on Public Acceptance of Using Large Language Models in Medicine
NCT07304908Large Language Models, Acceptability of Health Care, Perception, Self
Peking University
Not applicable
3,000
Beijing
2025-11-25
Recruiting
Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 ฮผg/Kgevery 8 Hours for Three Consecutive Days After Surgery.
NCT07514637Patients Who Undergo Pancreaticoduodenectomy
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
35
Nanjing
2025-11-25
Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
NCT07155174Small Cell Lung Cancer
AbbVie
Phase 2
180
Beijing, Zhengzhou, Wuhan, Nanchang, Shanghai, Chengdu
2025-11-25
Recruiting
A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia
NCT07229937Hyperlipidemia
Shandong Suncadia Medicine Co., Ltd.
Phase 2
189
Harbin
2025-11-25
Recruiting
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC
NCT07742332EGFR, NSCLC (Non-small Cell Lung Cancer), Locally Advanced Non-Small Cell Lung Cancer, Radiotherapy
Peng Zhang
Phase 2
160
Shanghai
2025-11-25
Not yet open
Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome
NCT07240376Non-Allergic Rhinitis With Eosinophilia Syndrome
Huazhong University of Science and Technology
Not applicable
90
Guangzhou, Wuhan, Xiangyang, Nanchang, Chengdu, Beijing, Shanghai
2025-11-25
Recruiting
A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors
NCT07269899Solid Tumor Cancer, Cancer
Sun Yat-sen University
Phase 1
12
Guangzhou
2025-11-25
Recruiting
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan
NCT07537673Nausea and Vomiting Caused by Trastuzumab Deruxtecan
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hangzhou
2025-11-25
Recruiting
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOYยฎ (US-Sourced YERVOYยฎ) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
NCT07176650Hepatocellular Carcinoma (HCC)
Shanghai Henlius Biotech
Phase 1
246
Beijing, Bengbu, Changchun, Changsha, Chengdu, Dongguan, Fuzhou, Ganzhou
2025-11-25
By invitation
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
NCT07256392Chronic Spontaneous Urticaria
Celldex Therapeutics
Phase 3
1,370
2025-11-25
Recruiting
SA1211 Injection Phase 1 Study
NCT07275918Chronic Hepatitis B
Suzhou Siran Biotechnology Co.,Ltd.
Phase 1
80
Changchun
2025-11-25
Recruiting
Nephron-sparing Treatment of Tislelizumab + Nab-Paclitaxel for Renal Pelvic Cancer
NCT07233252Renal Pelvic Carcinoma, Tislelizumab, PD-1 Inhibitor, Kidney-sparing
Tianjin Medical University Second Hospital
Phase 2
35
Tianjin
2025-11-25
Recruiting
Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years
NCT07300644Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd.
Phase 2
420
Huanggang, Xiangyang, Xianning
2025-11-25
Recruiting
Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma
NCT07355699Marginal Zone Lymphoma(MZL)
Beijing Tongren Hospital
Phase 4
88
Beijing
2025-11-25
Active, closed
A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis
NCT07136805Non-infectious Anterior Uveitis
VivaVision Biotech, Inc
Phase 3
154
Chongqing, Beijing
2025-11-25
Recruiting
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel
NCT07537660Nausea and Vomiting Caused by Chemotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hangzhou
2025-11-25
Recruiting
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
NCT07286175Bipolar Disorder
Eli Lilly and Company
Phase 2
400
Changsha, Hangzhou, Huzhou, Jinan, Shanghai, Shijiazhuang, Tianjin, Xiamen
2025-11-24
Recruiting
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
NCT07236762Systemic Lupus Erythematosus, Lupus Nephritis (LN), Sjogren's Syndrome, Inflammatory Myopathy
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
18
Bengbu
2025-11-24
Recruiting
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT07174310Parkinson's Disease
Hoffmann-La Roche
Phase 3
900
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Nanjing
2025-11-24
Recruiting
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis
NCT07029178Radiation Induced Oral Mucositis, Radiodermatitis
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
160
Shanghai
2025-11-24
By invitation
RCT on Traditional Exercise Interventions for Physical and Mental Health in Hearing-Impaired Individuals
NCT07259694Hearing-Impaired
Northeast Normal University
Not applicable
90
Changchun
2025-11-24
Not yet open
Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease
NCT07250685PD - Parkinson's Disease
Zhang Jianguo
Not applicable
86
Beijing, Wuhan, Nanjing, Dalian, Jinan, Shanghai, Tianjin, Hangzhou
2025-11-24
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
AstraZeneca
Phase 1/2
152
Chengdu, Chongqing, Deyang, Fuzhou, Guangzhou, Jinan, Shanghai, Shenyang
2025-11-24
Recruiting
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
NCT07229729Non-small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 2
300
Guangzhou
2025-11-24
Recruiting
JN002 for the Treatment of Dry Eye Disease
NCT07245017Dry Eye
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1
30
Shanghai
2025-11-24
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies
NCT07368478Advanced Solid Malignancies
Biocity Biopharmaceutics Co., Ltd.
Phase 1
180
Shanghai
2025-11-24
Recruiting
A Phase Ia Clinical Trial of HW241045
NCT07448194Healthy Volunteers, IPF
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Phase 1
56
Beijing
2025-11-24
Recruiting
Specialist Nurse-Led Nursing Management for Patients Undergoing Head and Neck Cancer Surgery
NCT07622381Head & Neck Cancer
Tianjin Medical University Cancer Institute and Hospital
Not applicable
80
Tianjin
2025-11-24
Recruiting
Comparison of the Efficacy and Safety of Ciprofol Versus Propofol for Sedation in ICU Patients Undergoing Non-Invasive Ventilation
NCT07536750Respiratory Failure, Critical Illness
Nanfang Hospital, Southern Medical University
Observational
1,680
Guangzhou
2025-11-24
By invitation
Concept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen
NCT07514728Breast Cancer, Lung Metastasis, Hyperbaric Oxygen Therapy
Jinan Central Hospital
Not applicable
10
Jinan
2025-11-24
Not yet open
A Study of Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer
NCT07254156Colorectal Cancer, MRD, ctDNA
Sun Yat-sen University
Observational
229
Guangzhou
2025-11-24
Recruiting
Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal Adenoma
NCT06930157Low-risk Colorectal Adenoma
Shanghai Jiao Tong University School of Medicine
Phase 4
624
Shanghai
2025-11-24
Recruiting
A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy
NCT07330544Breast Cancer
Zhejiang Cancer Hospital
Phase 2
118
Zhejiang
2025-11-24
Recruiting
Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors
NCT07301853Living Donor Liver Transplantation Recipients, Deceased Donor Liver Transplantation Recipients, Living Liver Donor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
9,999
Hangzhou
2025-11-24
Recruiting
Closed-Loop Neurofeedback Targeting the Left Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety
NCT07244484Coronary Heart Disease (CHD), Anxiety Disorders
Shenyang Medical College
Not applicable
56
Shenyang
2025-11-23
Recruiting
A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients With Alzheimer's Disease.
NCT07059871AD - Alzheimer's Disease, Sarcopenia, Asthenia
Zhejiang Hospital
Not applicable
200
Hangzhou
2025-11-23
Recruiting
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
NCT07279493Acute Ischemic Stroke
Kunming Pharmaceuticals, Inc.
Phase 2
300
Beijing, Shenzhen, Cangzhou, Hengshui, Daqing, Anyang, Nanyang, Xuzhou
2025-11-22
Recruiting
FMS-CrossFit Training Program (FCTP) to Improve School Readiness in Preschool Children With Autism Spectrum Disorder
NCT07532395Autism Spectrum Disorder
Peking University
Not applicable
184
Fuzhou
2025-11-22
Recruiting
Intraosseous Infusion in Hematologic Critical Patients
NCT07239375Intraosseous Infusions
Shanxi Bethune Hospital
Observational
52
Taiyuan
2025-11-22
Active, closed
Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza A
NCT07229807Influenza a
Guangdong Raynovent Biotech Co., Ltd
Phase 3
119
Beijing
2025-11-22
Recruiting
Effect of Visual-Guided Balance Training on Knee Motor Function and Biomechanical Characteristics After ACL Reconstruction
NCT07306221Anterior Cruciate Ligament Injuries
Peking University Third Hospital
Not applicable
45
Beijing
2025-11-22
Recruiting
A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis
NCT07229742Active Lupus Nephritis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
51
Nanjing
2025-11-22
Recruiting
A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening
NCT07395479Advanced Malignant Tumours
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
50
Beijing
2025-11-21
By invitation
Dynamic Effects of Different Anesthetic Agents on the Immune Function of Healthy Volunteers
NCT07268872Immune System
Henan Provincial People's Hospital
Not applicable
80
Henan
2025-11-21
Active, closed
Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging
NCT06632912Human Papillomavirus (HPV) Infection, HPV (Human Papillomavirus)-Associated Carcinoma
National Vaccine and Serum Institute, China
Phase 3
1,800
Heze, Liaocheng, Taiโ€™an
2025-11-21
Recruiting
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
NCT07232875KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
588
Shanghai
2025-11-21
Recruiting
A Study of GensSci098 in Subjects With Graves' Disease
NCT07286656Safety, Tolerability, GenSci098, Graves Disease
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
24
Shenyang
2025-11-21
Recruiting
Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of Hypophosphatemia.
NCT07233889Hypophosphatemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
60
Wuhan
2025-11-21
Recruiting
A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])
NCT07208058Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis
TJ Biopharma Co., Ltd.
Phase 3
30
Beijing, Guangzhou, Nanning, Shijiazhuang, Zhengzhou, Wuhan, Nanchang, Shenyang
2025-11-21
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
NCT07389629Iparomlimab and Tuvonralimab, Clear Cell Renal Cell Carcinoma, Neoadjuvant Therapy
Sun Yat-sen University
Phase 2
25
Guangzhou
2025-11-21
Recruiting
Asymptomatic TB With Innovative Modified Short-course Regimens
NCT06153069Tuberculosis
Huashan Hospital
Phase 4
426
Beijing, Liupanshui, Nayong, Shanghai, Hangzhou
2025-11-21
Recruiting
Exploratory Trial of Navigational Bronchoscopy-Guided Cryoablation in Lung Cancer Treatment
NCT07301411Lung Malignancies
Tianjin Puli Ark Medical Technology Co., Ltd.
Not applicable
40
Shanghai
2025-11-21
Recruiting
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough - China Extension
NCT07650084Refractory Chronic Cough
GlaxoSmithKline
Phase 3
75
Leshan, Beijing, Changsha, Chengdu, Chongqing, Dongguan, Ganzhou, Guangzhou
2025-11-21
Recruiting
Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT07622797Late-stage Resectable Esophageal Squamous Carcinoma
The First Affiliated Hospital of Henan University of Science and Technology
Phase 2
164
Luoyang
2025-11-21
Recruiting
IASO208 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies
NCT07309900Relapsed/Refractory B-cell Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1
12
Wuhan
2025-11-21
Recruiting
Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules
NCT07232433Lung Cancer
Ruijin Hospital
Not applicable
90
Shanghai
2025-11-21
Recruiting
Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma
NCT07371923Diffuse Large B Cell Lymphoma (DLBCL)
Beijing Tongren Hospital
Phase 2
50
Beijing
2025-11-20
Recruiting
AI-assisted Endoscopic Ultrasound Grading of Early Esophageal Cancer Invasion Depth: A Multicenter, Prospective, Randomized Cohort Study
NCT07251114Esophageal Cancer Stage, Early Esophageal Cancer
Fujian Provincial Hospital
Not applicable
200
Fuzhou, Putian
2025-11-20
Not yet open
Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients
NCT06683131Acute Myocardial Infarction (AMI)
The Affiliated Hospital of Xuzhou Medical University
Phase 4
1,160
Fuyang, Huai'an, Lianyungang, Nanjing, Suqian, Xuzhou, Beijing, Shanghai
2025-11-20
Not yet open
Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension
NCT07232966Resistant Hypertension
Yan Li
Phase 3
220
Shanghai
2025-11-20
By invitation
Traditional Exercise RCT in Visually Impaired Adults
NCT07265024Visual Impairments
Northeast Normal University
Not applicable
90
Changchun
2025-11-20
Recruiting
A Phase I/II Clinical Study of WJ22096 Tablets in Patients With Advanced Tumors
NCT07253116Advanced Solid Tumors
Nanjing Jingao biomidical technology Co. Ltd.
Phase 1/2
20
Beijing
2025-11-20
Not yet open
Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication๏ผˆFrequency Adjusted Same-dose Therapy for H. Pylori๏ผ‰
NCT07242443HELICOBACTER PYLORI INFECTIONS
First People's Hospital of Hangzhou
Phase 4
240
Hangzhou
2025-11-20
Recruiting
Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients
NCT07252102Liver Cirrhosis, Polyps of Colon, Gastrointestinal Dysfunction
Zhejiang University
Not applicable
450
Shenzhen, Hangzhou
2025-11-20
Recruiting
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
NCT07241793Urothelial Carcinoma, Advanced Urothelial Carcinoma, Urothelial Carcinoma Recurrent
Sun Yat-sen University
Phase 2
96
Guangzhou, Wuhan, Nanchang, Kunming
2025-11-20
Recruiting
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
NCT07216027Atopic Dermatitis, Eczema, Atopic
Pfizer
Phase 2
165
Shanghai, Beijing
2025-11-20
Recruiting
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
NCT07328854Nasopharyngeal Carcinoma
Ming-Yuan Chen
Phase 3
346
Hefei, Fuzhou, Guangzhou, Shantou, Zhongshan, Zhuhai, Nanning, Wuzhou
2025-11-20
Recruiting
A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors
NCT07231211Solid Tumors
Shanghai Shengdi Pharmaceutical Co., Ltd
Phase 1/2
258
Hangzhou
2025-11-20
Recruiting
Prospective Cohort Control Study on Changes in Gut Microbiota in Ischemic Stroke
NCT07247838Ischemic Stroke
Affiliated Hospital of Nantong University
Observational
200
Nantong
2025-11-19
Recruiting
The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks
NCT07270887ASCVD
General Hospital of Shenyang Military Region
Observational
2,800
Shenyang
2025-11-19
Recruiting
Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma
NCT07144423Chronic Subdural Hematoma
Beijing Tiantan Hospital
Not applicable
770
Beijing, Xiamen, Jiangmen, Shantou, Shenzhen, Liuzhou, Nanning, Wuzhou
2025-11-19
Active, closed
A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome
NCT07211685Alport Syndrome
Bayer
Phase 2
60
Beijing, Chongqing, Guangzhou, Wuhan, Hangzhou
2025-11-19
Recruiting
GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
NCT06921317Primary Open-Angle Glaucoma (POAG)
IVIEW Therapeutics Inc.
Phase 1/2
6
Suzhou
2025-11-19
Recruiting
High-Intensity, Low-Frequency Periodic rTMS Over the Right Dorsolateral Prefrontal Cortex on Cardiac Autonomic Regulation in Women With Recurrent Pregnancy Loss and Anxiety
NCT07233278Recurrent Pregnancy Loss(RPL), Anxiety
Shenyang Medical College
Not applicable
48
Shenyang
2025-11-19
Recruiting
Closed-Loop Neurofeedback Targeting the Right Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety
NCT07238920Coronary Heart Disease (CHD), Anxiety Disorders
Shenyang Medical College
Not applicable
56
Shenyang
2025-11-19
Recruiting
GenSci139 in Patients With Advanced Solid Tumors
NCT07230977Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
280
Jinan
2025-11-19
Recruiting
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
NCT07343791DC-CIK Treatment, Regorafenib, Colorectal Cancer, Immune Combination Therapy
JIANG LONGWEI
Phase EARLY_PHASE1
14
Nanjing
2025-11-19
Recruiting
The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease.
NCT07243184Severe Mitral Valve Regurgitation, Severe Mitral Valve Stenosis
Shanghai HeartEpoch Medical Technology Co., Ltd
Not applicable
10
Beijing
2025-11-19
Not yet open
A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases
NCT07249892Metastatic Solid Tumors
Chengdu Syncor Pharmaceutical Co., Ltd.
Phase 1/2
195
Guangzhou
2025-11-19
Active, closed
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study
NCT07216976Parkinson's Disease
MedtronicNeuro
Not applicable
61
Beijing, Guangzhou, Shanghai, Chengdu
2025-11-19
Recruiting
A Phase 1 Study of HDM2017 in Advanced Solid Tumors
NCT07274085Solid Tumors
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
96
Beijing
2025-11-18
Recruiting
Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
NCT07363460Lupus Nephritis (LN)
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
105
Nanjing
2025-11-18
Recruiting
Transcutaneous Electrical Acupoint Stimulation for Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
NCT07235371Postoperative Urinary Retention (POUR)
Lu Chao
Not applicable
76
Hangzhou
2025-11-18
Recruiting
Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
NCT07233720Marginal Zone Lymphoma
Henan Cancer Hospital
Observational
30
Zhengzhou
2025-11-18
Rows per page Showing 5201–5300 of 19052
Previous 51 52 53 54 55 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=53

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.